Abstract | OBJECTIVES:
Obatoclax is a pan-Bcl-2 inhibitor with promising efficacy, especially when combined with other antineoplastic agents. Pharmacokinetic drug-drug interactions can occur systemically and at the level of the tumour cell. Thus, this study scrutinised the interaction potential of obatoclax in vitro. METHODS: KEY FINDINGS:
Obatoclax induced the mRNA expression of several genes (e.g. CYP1A1, CYP1A2 and ABCG2 (five to seven-fold) through activation of the aryl hydrocarbon receptor in the nanomolar range. Obatoclax inhibits P-gp, BCRP and some CYPs at concentrations exceeding plasma levels. P-gp, MPR2 or BCRP overexpression did not influence the efficacy of obatoclax. CONCLUSIONS:
Obatoclax retains its efficacy in cells overexpressing P-gp, MRP2 or BCRP and might act as a perpetrator drug in interactions with drugs, for example being substrates of CYP1A2 or BCRP.
|
Authors | Dirk Theile, David Allendorf, Bruno Christian Köhler, Adam Jassowicz, Johanna Weiss |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 67
Issue 11
Pg. 1575-84
(Nov 2015)
ISSN: 2042-7158 [Electronic] England |
PMID | 26255619
(Publication Type: Journal Article)
|
Copyright | © 2015 Royal Pharmaceutical Society. |
Chemical References |
- ABCC2 protein, human
- ABCG2 protein, human
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
- Indoles
- Multidrug Resistance-Associated Protein 2
- Multidrug Resistance-Associated Proteins
- Neoplasm Proteins
- Pyrroles
- RNA, Messenger
- Cytochrome P-450 Enzyme System
- obatoclax
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(antagonists & inhibitors, genetics)
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
(antagonists & inhibitors, genetics)
- Animals
- Cell Line
- Cell Line, Tumor
- Cytochrome P-450 Enzyme System
(drug effects, genetics)
- Drug Interactions
- Drug Resistance, Multiple
- Gene Expression Regulation
(drug effects)
- Humans
- Indoles
- LLC-PK1 Cells
- Mice
- Multidrug Resistance-Associated Protein 2
- Multidrug Resistance-Associated Proteins
(genetics)
- Neoplasm Proteins
(antagonists & inhibitors, genetics)
- Pyrroles
(pharmacology)
- RNA, Messenger
(metabolism)
- Real-Time Polymerase Chain Reaction
- Swine
|